Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Quark Biotech enters research agreement with Sankyo for diabetes drug

Feb. 19, 1999

Ariad achieves second milestone in HMR collaboration

Feb. 19, 1999

Statins may be drugs of choice for adolescents with HeFH

Feb. 18, 1999

First orally active, nonsteroidal androgen receptor agonist discovered at Ligand

Feb. 18, 1999

Dainippon will initiate overseas trials of beta3 agonist

Feb. 18, 1999

Yamanouchi, Ono establish codevelopment and marketing agreement for bisphosphonate

Feb. 18, 1999

Preliminary results of testosterone replacement gel reported

Feb. 18, 1999

Sildenafil safe and effective in the treatment of ED in diabetic men

Feb. 17, 1999

ZD-4522 enters accelerated phase III trial program

Feb. 16, 1999

Cellegy initiates clinical trial with transdermal testosterone gel

Feb. 15, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...